ARID1A and neoplasm: To identify new therapeutic targets interfering with the underlying molecular pathology, several animal models were developed, including mice with a conditional doxycycline-induced Arid1a and/or Pten knockout [178], mice with endometrial autoimplantation and 7,12-Dimethylbenz[a]anthracene (DMBA) tumor induction [179].